NIH invests $23 million into a comprehensive HIV vaccine project : the IRB is among the grantees
on July 21, 2016 The IRB is part of an international team established by the Texas Biomedical Research Institute to develop multi-layered HIV defense strategy. Texas Biomedical Research Institute is one of the world’s leading independent biomedical research institutions dedicated to advancing health worldwide through innovative biomedical research. Dr. Ruth Ruprecht, Director of the Texas […]
New paper by the Lanzavecchia lab on Zika virus: antibodies identified with therapeutic and diagnostic potential
on July 14, 2016 A team of researchers from the Institute for Research in Biomedicine (IRB, USI Università della Svizzera italiana) and the Swiss biotech company Humabs BioMed SA has identified novel therapeutic monoclonal antibody candidates isolated from Zika-infected patients and new strategies for Zika virus diagnostics. An article published today in the renowned scientific […]
Tomasz Wypych awarded PhD
on July 13, 2016 Tomasz Wypych successfully defended his PhD thesis, which was presented at the University of Bern on March 21, 2016. His work, entitled “The role of B cells as antigen presenting cells in a mouse model of asthma” was performed in the laboratory of Federica Sallusto. His co-advisor was Prof. Jens Stein […]
New paper by the Lanzavecchia Lab on Cellular receptors for human cytomegalovirus discovered, a study published in Nature
on June 6, 2016 A publication in the scientific journal Nature Microbiology identifies PDGFRα as the receptor for the trimeric gHgLgO complex of Human cytomegalovirus (HCMV). The study led by the Institute for Research in Biomedicine (IRB) affiliated to the Università della Svizzera italiana (USI) was done in collaboration with scientists from Humabs BioMed SA […]
Sara Montagner awarded PhD
on May 20, 2016 Sara Montagner successfully defended her PhD thesis, which was presented at the University of Bern, Switzerland, on May 18, 2016. Her thesis title was “Understanding mast cell proliferation and functions via epigenetic modifications and microRNAs”, and the work was performed in the laboratory of Silvia Monticelli. Her co-supervisor was Prof. Hans-Uwe Simon, […]
Prof. Antonio Lanzavecchia elected member of the U.S. National Academy of Sciences
on May 5, 2016 On May 3, 2016, Antonio Lanzavecchia has been elected, member of the U. S. National Academy of Sciences (NAS), one of the most significant and highest honors given to academic researchers. He was among the 21 new foreign associates from 14 countries, and 84 new members from the US elected this […]
New paper on epigenetic regulation of gene expression by the lab of Silvia Monticelli published in Cell Reports
on May 4, 2016 A new article published in Cell Reports describes how an enzyme involved in regulating DNA demethylation processes impacts differentiation and proliferation of mast cells. TET2 is an enzyme involved in the regulation of DNA methylation dynamics that is frequently found mutated in myeloid malignancies such as systemic mastocytosis. This study, mainly […]
Viola Puddinu and Timothy Bergmann IRB Student awardees 2015-2016
on April 19, 2016 During the annual IRB Student Retreat, which took place on April 6 – 8 in Engelberg, Viola Puddinu (Signal Transduction Lab) and Timothy Bergmann (Protein Folding and Quality Control Lab) were announced as the grantees of the fourth IRB student award. This award is meant to acknowledge the students’ participation, effort […]
Giorgia Brambilla Pisoni awarded PhD
on March 10, 2016 Giorgia Brambilla Pisoni successfully defended her PhD thesis, which was presented at the ETH of Zurich, Switzerland. In her thesis, entitled “In vivo characterization of TMX1: TMX1 preferentially acts upon transmembrane polypeptides” Giorgia presented her contribution to the better characterization of poorly characterized members of the protein disulfide isomerase (PDI) superfamily […]
New paper by the Lanzavecchia Lab on Protective human-derived antibody against Ebola successfully isolated and characterized
on February 25, 2016 The Institute for Research in Biomedicine (IRB), affiliated to the Università della Svizzera italiana (USI), and Humabs BioMed SA, a Swiss antibody therapeutics company, have identified, isolated and characterized two Ebola virus neutralizing monoclonal antibodies from the blood of a survivor of an Ebola infection. The results were achieved through an […]
